We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Hvivo Plc | LSE:HVO | London | Ordinary Share | GB00B9275X97 | ORD 0.1P |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.75 | 2.75% | 28.00 | 27.60 | 28.00 | 27.80 | 27.25 | 27.25 | 1,993,935 | 16:35:24 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| Pharmaceutical Preparations | 56.04M | 16.12M | 0.0237 | 11.71 | 185.4M |
From Jul 2019 to Jul 2024
TIDMVENN
RNS Number : 5582Q
Venn Life Sciences Holdings PLC
06 June 2018
Venn Life Sciences Holdings Plc
("Venn" or the "Company" or the "Company")
Notice of AGM and Posting of Annual Report and Accounts
Venn Life Sciences (AIM: VENN), an Integrated Drug Development Partner offering a combination of drug development expertise and clinical trial design and management to pharmaceutical, biotechnology and medical device clients, announces that the Annual Report and Accounts for the year ended 31 December 2017 have been posted to shareholders, together with Notice of the Annual General Meeting and a Form of Proxy.
The Annual General Meeting is to be held on Wednesday 27 June 2018 at 12 noon at the Heathrow Marriot, Bath Rd, Harlington, Hayes, UB3 5AN.
The Annual Report and Accounts and the Notice of Annual General Meeting will be on the website at www.vennlifesciences.com/investors
Enquiries:
Venn Life Sciences Holdings Plc Tel: +353 1 549 9341 Allan Wood, Non-Executive Chairman Tony Richardson, Chief Executive Officer Cenkos (Nominated Advisor and Co-Broker) Tel: +44 (0) 20 7397 8900 Mark Connelly/Steve Cox (Corporate Finance) Davy (ESM Adviser and Co-Broker) Fergal Meegan / Matthew de Vere White Tel: +353 1 679 6363 (Corporate Finance) Hybridan (Co-Broker) Claire Louise Noyce Tel: +44(0) 20 3764 2341 Walbrook PR Ltd Tel: +44(0)20 7933 8787 Paul McManus/ Anna Dunphy
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
END
ACSKMGGVKVMGRZM
(END) Dow Jones Newswires
June 06, 2018 11:55 ET (15:55 GMT)
1 Year Hvivo Chart |
1 Month Hvivo Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
